Alamar Biosciences, Inc.

🚀Alamar Biosciences Unveils Game-Changing NULISAqpcr™ Custom Assay Development Kit! We’re thrilled to announce the launch of the #NULISAqpcr Custom Assay Development Kit, designed to empower researchers in creating highly sensitive and precise biomarker assays for clinical research. This groundbreaking kit enables scientists to develop targeted assays with their own antibodies, offering exceptional sensitivity and reproducibility, and seamlessly integrates with the #ARGO HT instrument to set a new standard in assay development. 👉 Learn more: https://ow.ly/Tzm150V6hSM

🚨 Head over to the exhibit hall to view our posters featuring cutting-edge NULISA technology. Discover how #NULISA is advancing biomarker discovery and proteome profiling, with applications in aging, inflammation, and CNS diseases. Don’t miss the chance to see how it’s driving groundbreaking research—stop by and learn more! #USHUPO2025

🚨 Happening TODAY at #USHUPO2025! 🚨 Join us at 3:15 pm for a lightning talk by Xiao-Jun Ma, CTO of Alamar, on aging-associated protein biomarkers in plasma using #NULISA technology. Don't forget to stop by Booth 14 for a demo of the #ARGO HT System and to chat with our team about your research goals! 👉 https://ow.ly/ck8X50V3My0

As part of our newly launched Certified Service Provider (CSP) Program, we’re thrilled to showcase Frontage Laboratories, Inc, a trusted leader in biomarker testing and research. With their advanced capabilities and expertise in drug development, Frontage Labs is helping to drive innovation in the life sciences. We’re proud to have Frontage Labs as part of our CSP network, providing top-tier services that support scientists in achieving their research goals. 🌐 Learn more about their services: https://lnkd.in/gWQqg9v6 💡 Interested in becoming a Certified Service Provider? Visit our CSP page to learn more about how you can join our growing network and deliver trusted solutions to the scientific community: https://lnkd.in/guT4rPH2 https://lnkd.in/gKX-XPAE

🌟 Don't Miss Our Lightning Talk at #USHUPO2025! 🌟 Join us on Monday, Feb. 24, at 3:15 pm, to hear from Xiao-Jun Ma, CTO at Alamar, present groundbreaking research on aging-associated protein biomarkers in plasma, using #NULISA technology. Be sure to visit us at Booth 14 to speak with our team about your research goals and to demo the fully-automated #ARGO HT System 👉 https://ow.ly/ck8X50V3My0

🚀 Exciting News from Alamar Biosciences! We are excited to announce the launch of our Certified Service Provider (CSP) Program! This new initiative will expand access to our cutting-edge #NULISA technology for academic and biopharmaceutical researchers, empowering them with high-sensitivity, multiplexed protein quantification for groundbreaking discoveries. Our CSP Program represents a huge milestone in enabling early disease detection and accelerating scientific advancements. Learn more about the Program and how your lab can become certified 👉 https://ow.ly/T68z50V2vLn

🚀 Exciting News from Alamar Biosciences! We are excited to announce the launch of our Certified Service Provider (CSP) Program! This new initiative will expand access to our cutting-edge #NULISA technology for academic and biopharmaceutical researchers, empowering them with high-sensitivity, multiplexed protein quantification for groundbreaking discoveries. Our CSP Program represents a huge milestone in enabling early disease detection and accelerating scientific advancements. Learn more about the Program and how your lab can become certified 👉 https://ow.ly/T68z50V2vLn

Join us for our Sponsored Breakfast Seminar at #USHUPO2025! Hear from Dr. Hanno Steen, (Harvard Medical School) and Dr. Yuehan Feng, (Biognosys) as they discuss how the #NULISA platform advances plasma cytokine and chemokine detection to complement mass spec in human proteome research. Stop by booth 14 to speak with our team about your research goals and to demo the fully-automated #ARGO HT System 👉 https://ow.ly/lenH50V1Jg0

We are excited to return to #USHUPO2025, the premier event for proteomics research, in Philadelphia, PA! Join our Breakfast Symposium on Feb. 25, where we'll explore ultra-sensitive detection of plasma cytokines and chemokines with the #NULISA platform, and how it complements mass spec discovery to enhance #proteomics research. 🧬 Stop by booth 14 for the opportunity to network and learn about our cutting-edge solutions. See you in Philadelphia! https://ow.ly/IUi850UZB91

🚨 Groundbreaking Research on ALS Biomarkers 🚨 New research from Emory University using the #NULISA platform reveals that elevated neurofilament and tau #biomarkers in #ALS plasma correlate with disease progression. Higher pTau levels are linked to shorter survival and spinal onset ALS, suggesting shared pathological mechanisms between ALS and other neurodegenerative diseases. This major breakthrough has the potential to transform early diagnosis and disease monitoring—read the full publication to explore these exciting findings and their implications for the future of ALS research 👉 https://ow.ly/gttY50UX4Bb